View Older Stories

Jul 16, 2026 06:41AM Tempus AI Inc (TEM) PT Raised to $65 at Guggenheim

Jul 8, 2026 02:11PM Freedom Capital Starts Tempus AI Inc (TEM) at Hold

Jun 25, 2026 08:31AM Tempus AI partners with Angiosarcoma Awareness on rare cancer data

Jun 11, 2026 08:30AM Tempus publishes validation study for FDA-cleared ECG AI model

Jun 10, 2026 10:50AM TD Cowen notes short interest shifts in life science tools stocks

Jun 3, 2026 08:31AM Tempus launches open-source digital pathology consortium with Yale, MSK

Jun 2, 2026 06:50AM Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)

Jun 1, 2026 04:25PM Wolfe Research Assumes Tempus AI Inc (TEM) at Peerperform

May 29, 2026 09:15AM Tempus AI shares initial results from multimodal foundation model for oncology

May 28, 2026 08:31AM Tempus expands AI platform to six new cancer types for clinical insights

May 27, 2026 08:34AM Tempus upgrades Hub platform with generative AI clinical tools

May 26, 2026 08:31AM Tempus AI to present 37 research abstracts at 2026 ASCO meeting

May 21, 2026 08:31AM Tempus launches ArteraAI prostate test for metastatic patients

May 13, 2026 06:10AM Tempus AI completes $460 million convertible notes offering

May 11, 2026 07:11AM Tempus AI Inc (TEM) PT Lowered to $64 at H.C. Wainwright

May 6, 2026 08:02AM Lucent Diagnostics partners with Tempus AI for Alzheimer's blood testing

May 6, 2026 05:57AM Tempus AI Inc (TEM) PT Raised to $68 at TD Cowen

May 5, 2026 04:06PM Tempus AI, Inc (TEM) Misses Q1 EPS by 61c, provides guidance

Apr 15, 2026 08:32AM Tempus and Predicta partner on blood cancer genome testing assay

Apr 13, 2026 05:30AM TD Cowen Upgrades Tempus AI Inc (TEM) to Buy

Apr 13, 2026 03:27AM Jefferies Starts Tempus AI Inc (TEM) at Underperform

Apr 1, 2026 08:33AM Tempus AI shows improved heart valve treatment with alerts

Mar 10, 2026 07:21AM Tempus AI Inc (TEM) PT Raised to $95 at H.C. Wainwright

Feb 25, 2026 09:43AM Tempus AI Inc (TEM) PT Lowered to $60 at Stifel, Firm Highlights 'Solid' Outlook

Feb 24, 2026 04:04PM Tempus AI, Inc (TEM) Tops Q4 EPS by 16c, provides guidance

Feb 22, 2026 08:00PM This company's core business is undervalued, Mizuho says

Feb 19, 2026 05:28AM Mizuho Starts Tempus AI Inc (TEM) at Outperform

Feb 18, 2026 08:33AM Tempus launches AI-driven cancer algorithm for treatment selection

Feb 17, 2026 03:36AM Baird Starts Tempus AI Inc (TEM) at Outperform

Jan 27, 2026 08:33AM Tempus AI test outperforms standard biomarkers in predicting immunotherapy

Jan 21, 2026 08:30AM Tempus launches AI-powered biomarker prediction tool Paige Predict

Jan 12, 2026 07:00AM Northwestern Medicine partners with Tempus to expand cancer genomic testing

Jan 12, 2026 05:13AM Tempus AI (TEM) call put ratio 1.1 calls to 1 put into updated guidance

Jan 12, 2026 04:07AM Tempus AI reports preliminary 2025 revenue of $1.27 billion, up 83%

Jan 12, 2026 04:07AM Tempus AI reports record contract value exceeding $1.1 billion

Jan 8, 2026 08:32AM Tempus presents eight research abstracts at ASCO GI symposium

Dec 8, 2025 05:30AM TD Cowen Reiterates Hold Rating on Tempus AI Inc (TEM)

Nov 25, 2025 06:14AM Tempus AI Inc (TEM) PT Raised to $105 at BTIG

Nov 14, 2025 08:31AM Tempus partners with IFLI on follicular lymphoma research study

Nov 5, 2025 01:52AM Tempus AI Inc (TEM) PT Lowered to $95 at Canaccord Genuity

Nov 4, 2025 04:57PM Tempus AI, Inc (TEM) Reports Q3 Loss of $0.11, Offers Guidance

Nov 4, 2025 10:50AM Tempus AI (TEM) call put ratio 2.9 calls to 1 put into quarter results

Nov 3, 2025 11:00AM Tempus AI (TEM) call put ratio 1.4 calls to 1 put into quarter results

Oct 21, 2025 09:21AM Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock

Oct 21, 2025 05:26AM TD Cowen Downgrades Tempus AI Inc (TEM) to Hold

Oct 20, 2025 05:11AM Canaccord Genuity Reiterates Buy Rating on Tempus AI Inc (TEM)

Oct 16, 2025 08:32AM Tempus partners with Whitehawk Therapeutics for cancer research

Oct 1, 2025 12:24PM Ambry Genetics enhances breast cancer risk assessment tool with breast density

Sep 26, 2025 07:16AM Tempus AI Inc (TEM) PT Raised to $95 at Guggenheim

Sep 15, 2025 08:01AM Renalytix partners with Tempus AI to expand kidney disease testing

View Older Stories